期刊文献+

1993株临床分离细菌耐药性监测 被引量:10

Surveillance on antimicrobial resistance of 1993 clinical isolates
暂未订购
导出
摘要 目的调查我院2010年临床分离病原菌对抗菌药物的耐药性。方法采用纸片扩散法进行抗菌药物敏感实验,根据CLSI2010采用WHONET5.4软件进行数据分析。结果临床分类的1993株病原菌中,革兰阳性菌占21.2%,革兰阴性菌占78.8%;耐甲氧西林金黄色葡萄球菌和凝固酶阴性葡萄球菌株检出率分别为56.7%和91.9%;发现2株对万古霉素和替考拉宁耐药的屎肠球菌,表型及基因型检测为vanA型耐药;未发现对万古霉素或替考拉宁中介或耐药的葡萄球菌和粪肠球菌菌株。大肠埃希菌、肺炎克雷伯菌ESBLs检出率分别为61.7%、38.8%,大肠埃希菌ESBLs的菌株高于2008年(51.7%)和2009年(57.2%)监测比例。鲍曼不动杆菌对碳青霉烯类抗菌药物的耐药率在65%以上。结论对当地医院进行定期的细菌耐药监测,发现细菌的耐药变化趋势,对规范临床合理使用抗菌药物具有重要意义。 Objective To investigate the antimicrobial resistance of clinical isolates from the First Affiliated Hospital of Chongqing Medical University in 2010. Methods Disk diffusion method was used to determine the antimicrobial susceptibility. And the WHONET 5.4 software was used to analyze the data based on the CLSI2010. Results Of 1993 clinical isolates, gram-positive organisms accounted for 21.2%, and Gram-negative organisms 78.8%. The detection rates of methicillin-resistant Staphylococcus aureus (MRSA)and coagulase-negative staphylococci (CNS) were 56.7% and 91.9%, respectively. Two strains of Enterococcusfaecium were found resistant to vancomycin and teicoplanin. They were confirmed as vanA by phenotypic and genetic analysis. Extendedspectrum β-lactamases (ESBLs)-producing Escherichia coli and Klebsiella sp. were accounted for 61.7% and 38.8%, respectively. The frequency of ESBLs -producing E. coli was higher than that obtained in 2008 and 2009. The carbapenem resistance rate in Acinetobacter sp. was more than 65%, respectively. Conclusion Periodically bacterial resistance surveillance is of great importance for clinically rational usage of antimicrobials.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2012年第4期291-297,共7页 Chinese Journal of Antibiotics
基金 中国Chinet细菌耐药监测组部分资助
关键词 细菌 耐药 抗菌药物敏感性 Bacteria Resistance Antimicrobial susceptibility
  • 相关文献

参考文献19

  • 1Clinical and Laboratory Standards Institute (CLSI). M 100-S20.Performance standards for Antimicrobial Susceptibility testing, 19th Informational Supplement[S].Clinical and Laboratory Standards Institute,2010.
  • 2肖永红,李耘,马兴华.肠球菌耐药性与耐万古霉素基因检测[J].中华传染病杂志,2004,22(5):306-309. 被引量:4
  • 3汪复,朱德妹,胡付品,阮斐怡,倪语星,孙景勇,徐英春,张小江,胡云健,艾效曼,俞云松,杨青,孙自镛,李丽,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,薛建昌,张泓,李万华,徐元宏,沈继录,单斌,杜艳.2009年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2010,10(5):325-334. 被引量:398
  • 4朱德妹.2005年中国CHINET葡萄球菌属耐药性分析[J].中国感染与化疗杂志,2007,7(4):269-273. 被引量:73
  • 5Finan J E,Acher G L,Pucci M J. Role of penicillinbinding protein 4 in expression of vancomycin resistance among clinical isolates of oxacillin-resistant Staphylococcus aureus[J].Antimicrobial Agents and Chemotherapy,2001,(01):3070-3075.
  • 6Sievert D M,Boulton M L,Stoltman G. Staphylococcus aureus resistant to vancomycin-United States,2002[J].MM-WR,2002,(26):565-567.
  • 7Leclercq R,Derlot E,Duval J. Plasimid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium[J].New England Journal of Medicine,1988,(03):157-161.
  • 8Patel R. Clinniacl impact ofvancomycin-resistant enterococci[J].Antimi Chem,2003,(suppl S3):iii13-iii21.
  • 9Goossens H,Jabes D,Rossi R. European survey of wancomycin-resistant enterococci in at-risk hospital wards in vitro susceptibility testing of ramoplanin against these isolates[J].Journal of Antimicrobial Chemotherapy,2003,(Suppl 3):iii5-iii12.
  • 10肖永红,王进,赵彩云,高磊,郑波,薛峰,李湘艳,郝凤兰,代表Mohnarin协作组.2006-2007年Mohnarin细菌耐药监测[J].中华医院感染学杂志,2008,18(8):1051-1056. 被引量:608

二级参考文献80

共引文献1286

同被引文献76

引证文献10

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部